Skip to main content
Fig. 1 | BMC Pediatrics

Fig. 1

From: A case of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis with severe cardiac complications

Fig. 1

Clinical course of the patient and kinetics of EBV-DNA load and biomarkers. The patient had a rapid decrease in EBV-DNA load after initial treatments with chemotherapy that induced severe bone marrow suppression. No mononuclear cells were obtained from the patient during this period. CHDF, continuous hemodiafiltration; ACE-I, angiotensin-converting enzyme inhibitor; TM, thrombomodulin alpha; Dexa, dexamethasone; CSA, cyclosporine; VP-16, etoposide; CPA, cardiopulmonary arrest; EBV, Epstein-Barr virus, IFN; interferon, IL; interleukin, TNF; tumor necrosis factor

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us